Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy

Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy

Abstract Introduction Chimeric antigen receptor (CAR) T cell therapy has markedly improved the prognosis of patients with diffuse large B‐cell lymphoma (DLBCL). The relative positioning of tumor lesions in lymphoma varies among patients, manifesting as either aggregation (clumped together) or dissem...

Full description

Bibliographic Details
Main Authors: Xiuyong Dang, Ping Li, Aijun Shen, Yan Lu, Zeyv Zhu, Min Zhang, Wenbin Qian, Aibin Liang, Wenjun Zhang
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Cancer Medicine
Subjects:
chimeric antigen receptor T cell
diffuse large B‐cell lymphoma
prognosis
relative positioning of tumor lesions
Online Access:https://doi.org/10.1002/cam4.6991

Internet

https://doi.org/10.1002/cam4.6991

Similar Items